AI-Driven Discovery and Delivery Systems for Anti-Parkinsonian Agents.
Parkinson's disease is the second most widely diagnosed neurodegenerative disorder in the world, affecting more than 10 million people, with current drug therapies for treatment providing limited symptomatic relief and no effect on stopping disease progression. The integration of AI and Pharmaceutical Sciences has led...